Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...

We recently compiled a list of the Jim Cramer’s Top 12 Must-Watch Stocks. In this article, we are going to take a look at where Moderna Inc. (NASDAQ:MRNA) stands against Jim Cramer’s other must-watch ...

Moderna 's (NASDAQ: MRNA) stock fell by 13% on Sept. 12 upon the announcement of extensive cost cuts that would affect a ...

I am deeply troubled by the growing distrust of science in our society, just at the time when its insights are most needed.

Present Market Standing of Moderna Trading volume stands at 5,013,059, with MRNA's price down by -2.52%, positioned at $68.1. RSI indicators show the stock to be may be approaching oversold. Earnings ...

Health Canada has authorized Novavax's updated COVID-19 vaccine that protects against currently circulating variants of the ...

The latest, highly contagious subvariants are driving infections, but new vaccines may help stem the tide of another wave — ...

ME Therapeutics to begin testing of first mRNA formulations from NanoVation Therapeutics collaboration: Vancouver, British Columbia Friday, September 20, 2024, 14:00 Hrs [IST] ME ...

Japan's health ministry has approved five types of coronavirus vaccines for use in this season's campaign that starts on October 1.

In light of recent statements by Opposition Leader Kamla Persad-Bissessar and Health Minister Terrence Deyalsingh regarding ...

It was a busy week for the biotech sector with a lot of important data readouts at the European Society for Medical Oncology ...

NanoVation Therapeutics, a Vancouver company co-founded by biotech magnate Pieter Cullis, has struck a partnership with ...